当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析

安图生物

(603658)

  

流通市值:233.54亿  总市值:233.54亿
流通股本:5.71亿   总股本:5.71亿

安图生物(603658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润5.78亿元,每股收益1.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益855093.29万元,未分配利润423422.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1164538.40万元,负债309445.11万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,060,307,179.95995,933,663.324,471,202,509.223,380,035,059.48
营业总成本1,506,453,270.45746,443,403.963,307,150,305.922,408,355,902.26
其他经营收益
营业利润636,811,439.57303,498,951.951,245,488,947.451,064,101,986.71
利润总额638,845,435.17302,138,440.131,289,056,474.191,054,276,051.5
净利润578,036,989.75273,079,722.471,199,233,279.89969,432,633.28
每股收益
其他综合收益-8,422.01-12,112106,410.67-138,346.28
综合收益总额578,028,567.74273,067,610.471,199,339,690.56969,294,287
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计5,930,679,670.166,462,106,370.666,542,768,991.56,134,702,435.56
非流动资产:
非流动资产合计5,714,704,290.295,505,925,305.885,332,296,952.475,254,767,410.8
资产总计11,645,383,960.4511,968,031,676.5411,875,065,943.9711,389,469,846.36
流动负债:
流动负债合计2,531,681,037.532,462,122,219.572,659,547,350.972,387,938,078.06
非流动负债:
非流动负债合计562,770,036.38536,052,608.02523,722,740.07515,417,947.94
负债合计3,094,451,073.912,998,174,827.593,183,270,091.042,903,356,026
所有者权益(或股东权益):
归属于母公司股东权益合计8,458,066,259.738,876,936,827.168,616,530,318.048,402,371,569.16
股东权益合计8,550,932,886.548,969,856,848.958,691,795,852.938,486,113,820.36
负债和股东权益合计11,645,383,960.4511,968,031,676.5411,875,065,943.9711,389,469,846.36
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,320,053,939.831,210,943,311.025,093,794,765.323,754,808,838.97
经营活动现金流出小计1,909,870,014.481,044,604,852.763,784,512,024.22,805,843,424.31
经营活动产生的现金流量净额410,183,925.35166,338,458.261,309,282,741.12948,965,414.66
投资活动产生的现金流量:
投资活动现金流入小计2,767,973,416.1410,024,513.892,623,053,898.831,427,587,597.82
投资活动现金流出小计2,465,838,886.17391,016,832.233,808,281,321.692,400,651,358.7
投资活动产生的现金流量净额302,134,529.97-380,992,318.34-1,185,227,422.86-973,063,760.88
筹资活动产生的现金流量:
筹资活动现金流入小计1,295,522,997.74746,196,189.371,286,955,484.921,062,161,991.98
筹资活动现金流出小计2,008,806,278.48767,303,924.892,445,785,430.422,204,222,151.44
筹资活动产生的现金流量净额-713,283,280.74-21,107,735.52-1,158,829,945.5-1,142,060,159.46
汇率变动对现金及现金等价物的影响3,246,257.443,228,949.871,463,670.6541,957.13
现金及现金等价物净增加额2,281,432.02-232,532,645.73-1,033,310,956.64-1,165,616,548.55
期末现金及现金等价物余额454,339,780.83219,525,703.08452,058,348.81319,752,756.9
补充资料:
现金及现金等价物的净增加额2,281,432.02--1,033,310,956.64-
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
信达证券唐爱金,曹佳琳2.142.462.892025-08-26
国海证券年庆功2.262.602.952025-08-25
中信证券宋硕,陈竹,曾令鹏2.192.432.752025-08-25
光大证券王明瑞,黎一江2.212.583.012025-08-24
中金公司俞波,张琎,陈诗雨2.142.34--2025-08-24
TOP↑